| Ident. | Authors (with country if any) | Title |
|---|
| 000734 (2020) |
Alexis Mathian [France] ; Marc Pineton De Chambrun [France] ; Alain Combes [France] ; Zahir Amoura [France] | Response to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra et al. |
| 000748 (2020) |
M. Pineton De Chambrun [France] ; C. Frere [France] ; M. Miyara [France] ; Z. Amoura [France] ; I. Martin-Toutain [France] ; A. Mathian [France] ; G. Hekimian [France] ; A. Combes [France] | Response to Letter: 'Reply to "High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?"'. |
| 000813 (2020) |
Laurent Dortet ; Cecile Emeraud ; Christelle Vauloup-Fellous [France] ; Mouna Khecharem ; Jean-Baptiste Ronat [France] ; Nicolas Fortineau ; Anne-Marie Roque-Afonso [France] ; Thierry Naas | Rapid Determination of SARS-CoV-2 Antibodies Using a Bedside, Point-of-Care, Serological Test. |
| 000A41 (2020) |
Asmaa Hachim [République populaire de Chine] ; Niloufar Kavian [République populaire de Chine, France] ; Carolyn A. Cohen [République populaire de Chine] ; Alex W H. Chin [République populaire de Chine] ; Daniel K W. Chu [République populaire de Chine] ; Chris K P. Mok [République populaire de Chine] ; Owen T Y. Tsang [République populaire de Chine] ; Yiu Cheong Yeung [République populaire de Chine] ; Ranawaka A P M. Perera [République populaire de Chine] ; Leo L M. Poon [République populaire de Chine] ; J S Malik Peiris [République populaire de Chine] ; Sophie A. Valkenburg [République populaire de Chine] | ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. |
| 000A88 (2020) |
Ahidjo Ayouba [France] ; Guillaume Thaurignac [France] ; David Morquin [France] ; Edouard Tuaillon [France] ; Raisa Raulino [France] ; Antoine Nkuba [France] ; Audrey Lacroix [France] ; Nicole Vidal [France] ; Vincent Foulongne [France] ; Vincent Le Moing [France] ; Jacques Reynes [France] ; Eric Delaporte [France] ; Martine Peeters [France] | Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV. |
| 000B71 (2020) |
Pierre Gallian [France] ; Boris Pastorino [France] ; Pascal Morel [France] ; Jacques Chiaroni [France] ; Laetitia Ninove [France] ; Xavier De Lamballerie [France] | Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors. |
| 000B72 (2020) |
M L Solodky [France] ; C. Galvez [France] ; B. Russias [France] ; P. Detourbet [France] ; V. N'Guyen-Bonin [France] ; A-L Herr [France] ; P. Zrounba [France] ; J-Y Blay [France] | Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19. |
| 000E39 (2020) |
Narjis Boukli [France] ; Melchior Le Mene [France] ; Aurélie Schnuriger [France] ; Nancy Stella Cuervo [France] ; Cécilia Laroche [France] ; Laurence Morand-Joubert [France] ; Joël Gozlan [France] | High incidence of false positive results in patients with other acute infections, using the LIAISON® SARS-CoV-2 commercial chemiluminescent micro-particle immunoassay for detection of IgG anti SARS-CoV-2 antibodies. |
| 000E41 (2020) |
M. Pineton De Chambrun [France] ; C. Frere [France] ; M. Miyara [France] ; Z. Amoura [France] ; I. Martin-Toutain [France] ; A. Mathian [France] ; G. Hekimian [France] ; A. Combes [France] | High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? |
| 000F90 (2020) |
Christophe Martinaud [France] ; Carine Hejl [France] ; Alexandre Igert [France] ; Christine Bigaillon [France] ; Céline Bonnet [France] ; Audrey Mérens [France] ; Audrey Wolf [France] ; Vincent Foissaud [France] ; Isabelle Leparc-Goffart [France] | Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans. |
| 001103 (2020) |
Baptiste Demey [France] ; Nagib Daher ; Catherine François [France] ; Jean-Philippe Lanoix ; Gilles Duverlie [France] ; Sandrine Castelain [France] ; Etienne Brochot [France] | Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. |
| 001142 (2020) |
E. Tuaillon [France] ; K. Bolloré [France] ; A. Pisoni [France] ; S. Debiesse [France] ; C. Renault [France] ; S. Marie [France] ; S. Groc [France] ; C. Niels [France] ; N. Pansu [France] ; A M Dupuy [France] ; D. Morquin [France] ; V. Foulongne [France] ; A. Bourdin [France] ; V. Le Moing [France] ; P. Van De Perre [France] | Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients. |
| 001223 (2020) |
Phuoc-Bao-Viet Tong [France] ; Li-Yun Lin [France] ; Tuan Hiep Tran [Viêt Nam] | Coronaviruses pandemics: Can neutralizing antibodies help? |
| 001325 (2020) |
Julien Marlet [France] ; Camille Petillon [France] ; Emma Ragot [France] ; Yazid Abou El Fattah [France] ; Antoine Guillon [France] ; Sylvain Marchand Adam [France] ; Adrien Lemaignen [France] ; Louis Bernard [France] ; Guillaume Desoubeaux [France] ; Hélène Blasco [France] ; Francis Barin [France] ; Karl Stefic [France] ; Catherine Gaudy-Graffin [France] | Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting. |
| 001535 (2020) |
Daniela Andriuta [France] ; Pierre-Alexandre Roger [France] ; William Thibault [France] ; Bénédicte Toublanc [France] ; Chloe Sauzay [France] ; Sandrine Castelain [France] ; Olivier Godefroy [France] ; Etienne Brochot [France] | COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF. |
| 001561 (2020) |
M. Aubignat [France] ; O. Godefroy [France] | COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies? |
| 001624 (2020) |
Elisabeth Maillart [France] ; Caroline Papeix [France] ; Catherine Lubetzki [France] ; Thomas Roux [France] ; Valérie Pourcher [France] ; Céline Louapre [France] | Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies? |
| 001645 (2020) |
Paul Bastard [France, États-Unis] ; Lindsey B. Rosen [États-Unis] ; Qian Zhang [États-Unis] ; Eleftherios Michailidis [États-Unis] ; Hans-Heinrich Hoffmann [États-Unis] ; Yu Zhang [États-Unis] ; Karim Dorgham [France] ; Quentin Philippot [France] ; Jérémie Rosain [France] ; Vivien Béziat [France, États-Unis] ; Jérémy Manry [France] ; Elana Shaw [États-Unis] ; Liis Haljasm Gi [Estonie] ; P Rt Peterson [Estonie] ; Lazaro Lorenzo [France] ; Lucy Bizien [France] ; Sophie Trouillet-Assant [France] ; Kerry Dobbs [États-Unis] ; Adriana Almeida De Jesus [États-Unis] ; Alexandre Belot [France] ; Anne Kallaste [Estonie] ; Emilie Catherinot [France] ; Yacine Tandjaoui-Lambiotte [France] ; Jeremie Le Pen [États-Unis] ; Gaspard Kerner [France] ; Benedetta Bigio [États-Unis] ; Yoann Seeleuthner [France] ; Rui Yang [États-Unis] ; Alexandre Bolze [États-Unis] ; András N. Spaan [États-Unis, Pays-Bas] ; Ottavia M. Delmonte [États-Unis] ; Michael S. Abers [États-Unis] ; Alessandro Aiuti [Italie] ; Giorgio Casari [Italie] ; Vito Lampasona [Italie] ; Lorenzo Piemonti [Italie] ; Fabio Ciceri [Italie] ; Kaya Bilguvar [États-Unis] ; Richard P. Lifton [États-Unis] ; Marc Vasse [France] ; David M. Smadja [France] ; Mélanie Migaud [France] ; Jérome Hadjadj [France] ; Benjamin Terrier [France] ; Darragh Duffy [France] ; Lluis Quintana-Murci [France] ; Diederik Van De Beek [Pays-Bas] ; Lucie Roussel [Canada] ; Donald C. Vinh [Canada] ; Stuart G. Tangye [Australie] ; Filomeen Haerynck [Belgique] ; David Dalmau [Espagne] ; Javier Martinez-Picado [Espagne] ; Petter Brodin [Suède] ; Michel C. Nussenzweig [États-Unis] ; Stéphanie Boisson-Dupuis [France, États-Unis] ; Carlos Rodríguez-Gallego [Espagne] ; Guillaume Vogt [France] ; Trine H. Mogensen [Danemark] ; Andrew J. Oler [États-Unis] ; Jingwen Gu [États-Unis] ; Peter D. Burbelo [États-Unis] ; Jeffrey Cohen [États-Unis] ; Andrea Biondi [Italie] ; Laura Rachele Bettini [Italie] ; Mariella D'Angio [Italie] ; Paolo Bonfanti [Italie] ; Patrick Rossignol [France] ; Julien Mayaux [France] ; Frédéric Rieux-Laucat [France] ; Eystein S. Husebye [Norvège, Suède] ; Francesca Fusco [Italie] ; Matilde Valeria Ursini [Italie] ; Luisa Imberti [Italie] ; Alessandra Sottini [Italie] ; Simone Paghera [Italie] ; Eugenia Quiros-Roldan [Italie] ; Camillo Rossi [Italie] ; Riccardo Castagnoli [Italie] ; Daniela Montagna [Italie] ; Amelia Licari [Italie] ; Gian Luigi Marseglia [Italie] ; Xavier Duval [France] ; Jade Ghosn [France] ; John S. Tsang [États-Unis] ; Raphaela Goldbach-Mansky [États-Unis] ; Kai Kisand [Estonie] ; Michail S. Lionakis [États-Unis] ; Anne Puel [France, États-Unis] ; Shen-Ying Zhang [France, États-Unis] ; Steven M. Holland [États-Unis] ; Guy Gorochov [France] ; Emmanuelle Jouanguy [France, États-Unis] ; Charles M. Rice [États-Unis] ; Aurélie Cobat [France, États-Unis] ; Luigi D. Notarangelo [États-Unis] ; Laurent Abel [France, États-Unis] ; Helen C. Su [États-Unis] ; Jean-Laurent Casanova [France, États-Unis] | Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. |
| 001682 (2020) |
Virginie Siguret [France] ; Sebastian Voicu [France] ; Marie Neuwirth [France] ; Maxime Delrue [France] ; Etienne Gayat [France] ; Alain Stépanian [France] ; Bruno Mégarbane [France] | Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? |
| 001840 (2020) |
Ludivine Grzelak [France] ; Sarah Temmam [France] ; Cyril Planchais [France] ; Caroline Demeret [France] ; Laura Tondeur [France] ; Christèle Huon [France] ; Florence Guivel-Benhassine [France] ; Isabelle Staropoli [France] ; Maxime Chazal [France] ; Jeremy Dufloo [France] ; Delphine Planas [France] ; Julian Buchrieser [France] ; Maaran Michael Rajah [France] ; Remy Robinot [France] ; Françoise Porrot [France] ; Mélanie Albert [France] ; Kuang-Yu Chen [France] ; Bernadette Crescenzo-Chaigne [France] ; Flora Donati [France] ; François Anna [France] ; Philippe Souque [France] ; Marion Gransagne [France] ; Jacques Bellalou [France] ; Mireille Nowakowski [France] ; Marija Backovic [France] ; Lila Bouadma [France] ; Lucie Le Fevre [France] ; Quentin Le Hingrat [France] ; Diane Descamps [France] ; Annabelle Pourbaix [France] ; Cédric Laouénan [France] ; Jade Ghosn [France] ; Yazdan Yazdanpanah [France] ; Camille Besombes [France] ; Nathalie Jolly [France] ; Sandrine Pellerin-Fernandes [France] ; Olivia Cheny [France] ; Marie-Noëlle Ungeheuer [France] ; Guillaume Mellon [France] ; Pascal Morel [France] ; Simon Rolland [France] ; Felix A. Rey [France] ; Sylvie Behillil [France] ; Vincent Enouf [France] ; Audrey Lemaitre [France] ; Marie-Aude Créach [France] ; Stephane Petres [France] ; Nicolas Escriou [France] ; Pierre Charneau [France] ; Arnaud Fontanet [France] ; Bruno Hoen [France] ; Timothée Bruel [France] ; Marc Eloit [France] ; Hugo Mouquet [France] ; Olivier Schwartz [France] ; Sylvie Van Der Werf [France] | A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. |
